News
Recommended dose (s) for expansion and plans for dose expansion.
Experimental vaccines shrouded in controversy and targeted by health secretary Robert F Kennedy Jr may protect against one of ...
The American Cancer Society (ACS) has awarded The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai a $4.08 million grant to establish the Cancer Health Research Center at Mount ...
Among Janus kinase (JAK) inhibitor-naïve patients with myelofibrosis, treatment with the combination of pelabresib and ...
Cambridge based drug sleuth Bicycle Therapeutics has extended its cash runway from mid-2027 into 2028 as it closes in on ...
More than half of Yakima County's residents rely on Medicaid— delivered through Apple Health— for their health insurance. *Nearly 87% of county residents under the age of 19 count on Apple Health for ...
There was no doctor on-site when a patient arrived in early June at the emergency room (ER) in the small hospital at the intersection of two dirt roads in this town of 400 residents. There never is.
A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...
TRM analysts have determined that Embargo is likely a successor, or a rebranded version, of the BlackCat ransomware group.
New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.
Bayer announces deal with Kumquat for a pancreatic cancer KRAS inhibitor, plus, promising mRNA vaccine research emerges from ...
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced the first patient dosing in the U.S. for a clinical study of its novel nectin-4-targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results